Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Norsk Innovasjonskapital III is a Norwegian venture capital and investment vehicle associated with Televenture, not an operating biotech, pharma, or healthcare company. It appears to have been established in 2011 in Oslo, Norway, as a private limited company and part of the broader Norsk Innovasjonskapital fund family. Available sources indicate it functioned as an investment/fund entity rather than a developer of therapeutic products, and there is no evidence of an internal drug pipeline, platform technology, or healthcare operating business. Multiple business-registry-style sources indicate the entity is inactive or closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Norsk Innovasjonskapital III.